Pictet Asset Management (Switzerland)’s Tandem Diabetes Care TNDM Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,082	Closed	-$288K	–	2018
2023 Q1	$288K	Hold	7,082	–	–	﹤0.01%	1516
2022 Q4	$318K	Sell	7,082 -121,508	-94%	-$5.5M	﹤0.01%	1473
2022 Q3	$6.15M	Sell	128,590 -204,474	-61%	-$11.2M	0.01%	681
2022 Q2	$19.7M	Buy	333,064 +108,671	+48%	+$8.92M	0.03%	461
2022 Q1	$26.1M	Sell	224,393 -41,751	-16%	-$4.87M	0.03%	444
2021 Q4	$40.1M	Sell	266,144 -22,266	-8%	-$3.01M	0.04%	386
2021 Q3	$34.4M	Buy	+288,410	New	+$31.8M	0.04%	403

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s TNDM Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 7,082 shares — an estimated $288K sold.

Pictet Asset Management (Switzerland) first reported a position in TNDM in Q3 2021 and held it in 7 quarters. The position peaked at $40.1M in Q4 2021. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

Pictet Asset Management (Switzerland) reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 7,082 Tandem Diabetes Care shares in Q2 2023, an estimated $288K.
Pictet Asset Management (Switzerland) first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 7 quarters.
Pictet Asset Management (Switzerland)'s Tandem Diabetes Care position peaked at $40.1M in Q4 2021.
247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.